SCHEMBL9750234

SCHEMBL9750234

CCNc1ccc(N)cc1S(=O)(=O)NS(C)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.39
▸ GAA P10253 5/20 0.38
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ THRB P10828 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ PLEC Q15149 1/20 0.38
▸ RAPGEF4 Q8WZA2 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ CASP6 P55212 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ELAVL1 Q15717 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774567 0.85 CYP3A4 (0.40) L3MBTL1GAAMAPTALDH1A1KDM4E
SCHEMBL9748313 0.83 GAA (0.42) L3MBTL1GAAMAPTALDH1A1KDM4E
SCHEMBL9083398 0.80 RAPGEF4 (0.59) L3MBTL1GAAMAPTALDH1A1KDM4E
SCHEMBL9749274 0.77 LMNA (0.47) MAPTALDH1A1KDM4EHPGDHSD17B10
SCHEMBL9749683 0.77 L3MBTL1 (0.43) L3MBTL1GAAMAPTALDH1A1KDM4E
SCHEMBL10889640 0.76 CA12 (0.39) L3MBTL1GAAMAPTALDH1A1KDM4E
SCHEMBL10891838 0.75 SIGMAR1 (0.47) ALDH1A1GFERLMNAKMT2A
SCHEMBL10894158 0.74 GAA (0.50) L3MBTL1GAAALDH1A1POLBRECQL
SCHEMBL10889586 0.74 CA12 (0.43) L3MBTL1ALDH1A1HTTHSD17B10POLB
SCHEMBL10895262 0.73 L3MBTL3 (0.50) GAAALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed
EP-0205079-B1 ACID DISULFIMIDE TRIPHENODIOXAZINE DYES BAYER AG (DE) 1992-01-22 — — EP disclosed
EP-0205079-A2 Acid disulfimide triphenodioxazine dyes BAYER AG (DE) 1986-12-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION KRT18, ARSA, SQOR L3MBTL1 4874/4885GAA 872/4885MAPT 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback